5 Things You Need to Know About mRNA Technology

LS_mRNA_-Technology_infoG_2-22.jpg
 
 
Have Questions? Contact Us

Related Resources

Article

Navigating Sales Tax in the Life Science Industry: Challenges and Solutions

June 12, 2024
Article

Navigating Sales Tax in the Life Science Industry: Challenges and Solutions

June 12, 2024

The U.S. stands at the forefront of the life sciences industry, which is synonymous with innovation and technological breakthroughs. However, navigating the complexities of regulatory frameworks is crucial, particularly in understanding and complying with U.S. taxes, including state and local taxes.

Read More

Article

USTR Terminates Many Remaining Section 301 Exclusions but Requests Comments on a New Exclusion Process for Certain Manufacturing Equipment

June 3, 2024
Article

USTR Terminates Many Remaining Section 301 Exclusions but Requests Comments on a New Exclusion Process for Certain Manufacturing Equipment

June 3, 2024

When the Office of the U.S. Trade Representative (USTR) announced on May 13, 2024 the final results of its “sunset review” of the need for continuing the Section 301 “China tariffs,” it left unanswered the fate of the remaining 429 product-specific exclusions allowing importers to avoid paying the 25% or 7.5% duty.

Read More

Article

DHS Announces 26 New Additions to the UFLPA Entity List

May 31, 2024
Article

DHS Announces 26 New Additions to the UFLPA Entity List

May 31, 2024

On May 16, 2024, the Department of Homeland Security (DHS) announced the addition of 26 new companies to the UFLPA “Entity List” of companies known to engage in producing materials and goods with forced labor.

Read More

Article

Acquiring a Biotech Company? Follow Our Technical Due Diligence Checklist

May 31, 2024
Article

Acquiring a Biotech Company? Follow Our Technical Due Diligence Checklist

May 31, 2024

When private equity (PE) firms prepare for an M&A transaction, due diligence assessments help mitigate risk and safeguard a successful integration.

Read More